MedPath

Effects of Two Doses of Thylakoids on OGTT

Not Applicable
Completed
Conditions
Glucose Intolerance
Registration Number
NCT02702245
Lead Sponsor
Region Skane
Brief Summary

This cross-over intervention study aims to investigate the effect of two doses of thylakoids to an oral glucose tolerance test (OGTT) on glucose and insulin homeostasis as well as appetite regulating hormones in healthy volunteers.

Detailed Description

A minimum of twenty healthy volunteers are recruited to participate in an OGTT at three different occasions separated by one week. At two of the occasions a green leaf extract, thylakoids, is added to a glucose solution; 5 gram or 10 gram in randomized order. The third occasion, without added thylakoids, serve as control.

Blood samples are taken fasting and 15, 30, 45, 60, 90, 120 and 180 minutes after the glucose load.

Blood samples are analysed for p-glucose, p-insulin, p-C-peptide, p-ghrelin, p-CCK and p-GLP-1.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
21
Inclusion Criteria
  • Healthy
  • Adult
  • Normal-weight and weight stable
  • Not pregnant or breast-feeding
  • No use of medication that can affect glucose- and insulin homeostasis (for example corticosteroids).
Exclusion Criteria
  • Diabetes,
  • Impaired glucose tolerance and/or insulin resistance
  • Anaemia
  • Use of tobacco or drugs.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
Insulin sensitivity180 minutes, repeated at three occasions

Measurement of p-glucose, p-insulin and p-C-peptide in repeated blood sampling during three hours after an OGTT.

Secondary Outcome Measures
NameTimeMethod
p-GLP-1180 minutes, repeated at three occasions

Repeated blood sampling during three hours after an OGTT.

p-ghrelin180 minutes, repeated at three occasions

Repeated blood sampling during three hours after an OGTT.

© Copyright 2025. All Rights Reserved by MedPath